Stock listing
NASDAQ:IMDX Insight Molecular Diagnostics Inc. Stock
Home listing (NASDAQ) of Insight Molecular Diagnostics Inc.
Follow Insight Molecular Diagnostics Inc. into a list and get an email when it puts out news.
Share price · NASDAQ:IMDX
$2.96 USD -0.22 (-6.9%)
Close on Oct 30, 2026
- Day range
- $2.95 – $3.15 USDOct 30, 2026
- Volume
- 62,027 sharesOct 30, 2026
- Market cap
- $96.86M USDAt the close on Oct 30, 2026 · price × 32.72M shares outstanding
- 52-week range
- $2.42 – $8.51 USDLowest and highest trades, Oct 31, 2025 – Oct 30, 2026
- Traded on an average day
- $910,817 USDMedian day 206,500 shares · last 3 months, Jul 30, 2026 – Oct 30, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:IMDX · Home | $2.96 USD | -0.22 (-6.9%) | 62,027 | $3.12 | $3.15 | $2.95 | $3.18 | Close on Oct 30, 2026 |
| LSE:0KCC | $2.951 USD | +0.161 (+5.8%) | 6,161 | $3.075 | $3.075 | $2.951 | $2.79 | Close on Oct 27, 2026 |
Daily closes
Last 3 months, Jul 30, 2026 – Oct 30, 2026 · NASDAQ:IMDX · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $2.96 | -0.22 | -6.9% | $3.12 | $3.15 | $2.95 | 62,027 | |
| $3.18 | 0.00 | 0.0% | $3.15 | $3.20 | $3.09 | 111,905 | |
| $3.18 | +0.02 | +0.6% | $3.10 | $3.18 | $3.04 | 85,636 | |
| $3.16 | +0.16 | +5.3% | $3.06 | $3.25 | $2.926 | 306,875 | |
| $3.00 | +0.17 | +6.0% | $2.886 | $3.02 | $2.77 | 160,031 | |
| $2.83 | -0.01 | -0.4% | $2.84 | $2.921 | $2.76 | 42,478 | |
| $2.84 | -0.18 | -6.0% | $2.94 | $2.99 | $2.75 | 262,005 | |
| $3.02 | -0.01 | -0.3% | $3.04 | $3.10 | $2.89 | 300,290 | |
| $3.03 | +0.14 | +4.8% | $2.96 | $3.275 | $2.96 | 316,103 | |
| $2.89 | -0.12 | -4.0% | $3.01 | $3.025 | $2.78 | 474,153 | |
| $3.01 | -0.05 | -1.6% | $3.07 | $3.18 | $2.89 | 181,500 | |
| $3.06 | +0.27 | +9.7% | $2.81 | $3.12 | $2.79 | 177,700 | |
| $2.79 | -0.20 | -6.7% | $2.98 | $3.10 | $2.75 | 407,500 | |
| $2.99 | -0.18 | -5.7% | $3.16 | $3.20 | $2.943 | 313,000 | |
| $3.17 | -0.20 | -5.9% | $3.35 | $3.37 | $3.13 | 219,300 | |
| $3.37 | +0.09 | +2.7% | $3.29 | $3.441 | $3.19 | 156,400 | |
| $3.28 | -0.18 | -5.2% | $3.44 | $3.56 | $3.08 | 227,300 | |
| $3.46 | +0.08 | +2.4% | $3.35 | $3.665 | $3.26 | 153,900 | |
| $3.38 | -0.29 | -7.9% | $3.73 | $3.757 | $3.19 | 460,100 | |
| $3.67 | +0.23 | +6.7% | $3.44 | $3.74 | $3.17 | 408,400 | |
| $3.44 | -0.03 | -0.9% | $3.49 | $3.60 | $3.36 | 403,000 | |
| $3.47 | -0.12 | -3.3% | $3.57 | $3.625 | $3.24 | 394,600 | |
| $3.59 | +0.21 | +6.2% | $3.40 | $3.665 | $3.31 | 287,100 | |
| $3.38 | +0.20 | +6.3% | $3.23 | $3.505 | $3.07 | 311,200 | |
| $3.18 | -0.74 | -18.9% | $3.82 | $3.99 | $3.15 | 590,500 | |
| $3.92 | -0.03 | -0.8% | $3.99 | $4.002 | $3.76 | 313,500 | |
| $3.95 | +0.04 | +1.0% | $3.88 | $4.00 | $3.70 | 274,300 | |
| $3.91 | -0.23 | -5.6% | $4.08 | $4.08 | $3.65 | 597,300 | |
| $4.14 | +0.13 | +3.2% | $4.04 | $4.26 | $4.025 | 308,700 | |
| $4.01 | +0.01 | +0.2% | $4.09 | $4.13 | $3.84 | 253,500 | |
| $4.00 | +0.05 | +1.3% | $3.90 | $4.10 | $3.77 | 317,900 | |
| $3.95 | +0.37 | +10.3% | $3.67 | $3.98 | $3.51 | 197,700 | |
| $3.58 | -0.44 | -10.9% | $4.03 | $4.205 | $3.50 | 301,800 | |
| $4.02 | 0.00 | 0.0% | $3.99 | $4.24 | $3.77 | 213,400 | |
| $4.02 | -0.18 | -4.3% | $4.08 | $4.22 | $3.91 | 526,400 | |
| $4.20 | +0.22 | +5.5% | $4.06 | $4.228 | $3.94 | 173,600 | |
| $3.98 | -0.12 | -2.9% | $4.04 | $4.15 | $3.91 | 119,500 | |
| $4.10 | -0.17 | -4.0% | $4.26 | $4.26 | $4.013 | 188,800 | |
| $4.27 | +0.14 | +3.4% | $4.13 | $4.321 | $3.85 | 212,800 | |
| $4.13 | +0.01 | +0.2% | $4.10 | $4.18 | $3.99 | 183,500 | |
| $4.12 | +0.11 | +2.7% | $3.98 | $4.22 | $3.85 | 307,800 | |
| $4.01 | +0.17 | +4.4% | $3.81 | $4.04 | $3.71 | 80,800 | |
| $3.84 | -0.08 | -2.0% | $3.86 | $3.99 | $3.74 | 128,100 | |
| $3.92 | -0.21 | -5.1% | $4.10 | $4.115 | $3.88 | 102,400 | |
| $4.13 | -0.16 | -3.7% | $4.245 | $4.48 | $4.10 | 81,000 | |
| $4.29 | -0.01 | -0.2% | $4.27 | $4.32 | $4.23 | 36,400 | |
| $4.30 | -0.14 | -3.2% | $4.41 | $4.43 | $4.29 | 44,500 | |
| $4.44 | +0.12 | +2.8% | $4.35 | $4.54 | $4.35 | 155,942 | |
| $4.32 | -0.02 | -0.5% | $4.37 | $4.463 | $4.20 | 83,107 | |
| $4.34 | +0.04 | +0.9% | $4.40 | $4.455 | $4.31 | 38,700 | |
| $4.30 | -0.08 | -1.8% | $4.36 | $4.435 | $4.20 | 112,200 | |
| $4.38 | +0.10 | +2.3% | $4.29 | $4.50 | $4.25 | 146,900 | |
| $4.28 | +0.01 | +0.2% | $4.22 | $4.35 | $4.09 | 318,100 | |
| $4.27 | -0.05 | -1.2% | $4.29 | $4.365 | $4.01 | 97,100 | |
| $4.32 | +0.61 | +16.4% | $3.76 | $4.36 | $3.76 | 331,600 | |
| $3.71 | -0.79 | -17.6% | $4.47 | $4.485 | $3.54 | 1,161,900 | |
| $4.50 | +0.07 | +1.6% | $4.48 | $4.50 | $4.15 | 279,600 | |
| $4.43 | -0.34 | -7.1% | $4.60 | $4.881 | $4.20 | 522,300 | |
| $4.77 | -0.06 | -1.2% | $4.85 | $4.93 | $4.76 | 83,000 | |
| $4.83 | +0.03 | +0.6% | $4.85 | $4.935 | $4.70 | 42,000 | |
| $4.80 | -0.20 | -4.0% | $4.92 | $5.06 | $4.66 | 137,500 | |
| $5.00 | -0.12 | -2.3% | $5.23 | $5.26 | $4.90 | 107,300 | |
| $5.12 | +0.09 | +1.8% | $5.11 | $5.32 | $5.03 | 200,200 | |
| $5.03 | +0.38 | +8.2% | $4.73 | $5.22 | $4.605 | 293,300 | |
| $4.65 | +0.05 | +1.1% | $4.60 | $4.71 | $4.45 | 61,600 | |
| $4.60 | +0.23 | +5.3% | $4.41 | $4.658 | $4.41 | 95,500 |
- Ticker
- NASDAQ:IMDX
- Asset type
- Stock
- Sector
- Health care
- Industry
- Diagnostics & research services
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Oct 14, 2026
iMDx Welcomes New Diagnostics Sales Leader to Prepare for Planned GraftAssureDx Launch
Latest earnings call · Aug 10, 2026
Insight Molecular Diagnostics (NASDAQ:IMDX) Q2 2026 Earnings Call
Replay and transcript
Latest deck · Aug 10, 2026
Investor Presentation (August 2026)
Investor deck · 39 slides
Calls
Replays
Insight Molecular Diagnostics (NASDAQ:IMDX) Q2 2026 Earnings Call
Mon, Aug 10, 2026 · 5:00 PM ET
Watch TranscriptInsight Molecular Diagnostics (NASDAQ:IMDX) Q1 2026 Earnings Call
Wed, May 13, 2026 · 5:00 PM ET
Watch TranscriptInsight Molecular Diagnostics (NASDAQ:IMDX) Q4 2025 Earnings Call
Thu, Mar 26, 2026 · 5:00 PM ET
Watch Transcript
Latest news
iMDx Welcomes New Diagnostics Sales Leader to Prepare for Planned GraftAssureDx Launch
Oct 14, 2026
Closed $2.79 (-6.7%) on Oct 14, 2026
iMDx to Participate in Virtual U.S. Bancorp I BTIG Kidney Health Forum with KOL Discussion and Investor Meetings
Oct 12, 2026
Closed $3.17 (-5.9%) on Oct 12, 2026
iMDx to Participate in Lake Street 10th Annual Best Ideas Growth “BIG10” Conference
Sep 2, 2026
Closed $4.01 (+4.4%) on Sep 2, 2026
IMDX Reports Second Quarter 2026 Results and Timely Progress on FDA Review of GraftAssureDx
Aug 10, 2026
Closed $4.43 (-7.1%) on Aug 11, 2026
iMDx to Release Second Quarter Results on August 10, 2026 and Attend Needham Virtual MedTech & Diagnostics 1x1 Conference
Aug 4, 2026
Closed $5.12 (+1.8%) on Aug 4, 2026
iMDx GraftAssure Assay Guides Use of Potentially Kidney-Graft-Saving Drug in New Lancet Group Publication
Jul 23, 2026
Closed $4.96 (-0.6%) on Jul 23, 2026
IMDx Chief Science Officer Ekkehard Schuetz Publishes 200th Research Paper
Jun 29, 2026
Closed $5.42 (+0.4%) on Jun 29, 2026
iMDx and the American Society of Transplant Surgeons Announce Recipients of the ASTS-iMDx Health Economics Research Grant
Jun 22, 2026
Closed $5.40 (-0.7%) on Jun 22, 2026
Favorable Head-to-Head Data on iMDx’s GraftAssure with Competing NGS Assay Published in Clinical Chemistry
Jun 16, 2026
Closed $5.32 (0.0%) on Jun 17, 2026
IMDX GraftAssure Assay Sets New Standard in Screening Kidney Transplant Patients Per American Journal of Transplantation
Jun 11, 2026
Closed $5.43 (-5.7%) on Jun 11, 2026
Decks
Investor Presentation (August 2026)
Investor deck · 39 slides · Aug 10, 2026
Q1 2026 Earnings Presentation
Earnings · 28 slides · May 13, 2026
Investor Presentation (March 2026)
Investor deck · 37 slides · March 2026
Investor Presentation (February 2026)
Investor deck · 36 slides · Feb 11, 2026
Insight Molecular Diagnostics Inc. on 6ix
- Sector
- Health care
- Industry
- Diagnostics & research services
- News releases
- 28 in the last 12 months · 41 in all · newest Oct 14, 2026 · oldest 2025
- Calls
- 21 calls with a replay · 21 with a transcript · latest Aug 10, 2026
- Decks
- 28 decks · latest Aug 10, 2026
Where Insight Molecular Diagnostics Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:IMDX · Home listing · This page | NASDAQ | United States | USD |
| LSE:0KCC | LSE | United Kingdom | USD |
| BOATS:IMDX | BOATS | United States | USD |
| Frankfurt:7OC0 | Frankfurt | Germany | EUR |
| gettex:7OC0 | gettex | Germany | EUR |
| Munich:7OC0 | Munich | Germany | EUR |
| Tradegate:7OC0 | Tradegate | Germany | EUR |
Log in to ask 6ix AI your own questions about Insight Molecular Diagnostics Inc.